Cargando…

A Theranostic Approach to Target Gastrin in Pancreatic Cancer

Detalles Bibliográficos
Autores principales:	Banerjee, Sulagna, Saluja, Ashok K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008250/ https://www.ncbi.nlm.nih.gov/pubmed/29928679 http://dx.doi.org/10.1016/j.jcmgh.2018.04.002

Ejemplares similares

Learning From Gender Disparity: Role of Estrogen Receptor Activation in Coping With Pancreatic Cancer
por: Gupta, Vineet K., et al.
Publicado: (2020)

Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics
por: Abouzayed, Ayman, et al.
Publicado: (2023)

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

E-Cadherin: An Enigma in Pancreatic Diseases
por: Garrido, Vanessa T., et al.
Publicado: (2019)

GRP78‐mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells
por: Dauer, Patricia, et al.
Publicado: (2018)

CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization
por: Banerjee, Sulagna, et al.
Publicado: (2012)

Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2016)

The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies
por: Smith, Jill P., et al.
Publicado: (2016)

ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness”
por: Dauer, Patricia, et al.
Publicado: (2019)

miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
por: Chen, Zhiyu, et al.
Publicado: (2013)

Gastrin and Gastric Cancer
por: Waldum, Helge L., et al.
Publicado: (2017)

Gastrin and Gastric Cancer
por: Smith, Jill P., et al.
Publicado: (2017)

Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer
por: McGinn, Olivia, et al.
Publicado: (2017)

Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis
por: Pendharkar, Sayali A., et al.
Publicado: (2017)

Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer
por: Dauer, Patricia, et al.
Publicado: (2017)

Theranostic Probes for Cancer Imaging
por: Wang, Fu, et al.
Publicado: (2017)

Theranostics approach in drug development: is there study efficiency when the prevalence of the molecular target is very high?
por: Wang, Sue-Jane, et al.
Publicado: (2022)

Applications of Theranostics for Detecting and Targeting CNS Injuries and Diseases
por: Sun, Yu-Yo, et al.
Publicado: (2022)

Cyr61/CCN1 targets for chemosensitization in pancreatic cancer
por: Banerjee, Snigdha, et al.
Publicado: (2019)

O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability
por: Sharma, Nikita S, et al.
Publicado: (2019)

Nano-Carbons as Theranostics
por: Liu, Zhuang, et al.
Publicado: (2012)

Porphyrins and Phthalocyanines for Theranostics
por: Lovell, Jonathan F., et al.
Publicado: (2012)

Nanoprobes for Tumor Theranostics
por: Zhu, Jiaoyang, et al.
Publicado: (2022)

The central role of gastrin in gastric cancer
por: Waldum, Helge, et al.
Publicado: (2023)

The Biological Effects of Gastrin
por: Bennett, A.
Publicado: (1968)

Gastrin and the Moderate Hypergastrinemias
por: Rehfeld, Jens F.
Publicado: (2021)

Editorial to the IJMS Special Issue “Aptamer-Mediated Cancer Theranostics”
por: Danquah, Michael K.
Publicado: (2023)

Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways
por: Kesh, Kousik, et al.
Publicado: (2020)

“Albumin Hitchhiking” with an Evans Blue Analog for Cancer Theranostics
por: Ehlerding, Emily B., et al.
Publicado: (2018)

Magnetic Nanoparticle-Based Theranostics
por: Xie, Jin, et al.
Publicado: (2012)

Theranostic Upconversion Nanoparticles (I)
por: Chen, Guanying, et al.
Publicado: (2013)

Theranostic Hybrid Molecular Imaging
por: Gambini, Juan Pablo
Publicado: (2014)

Theranostic Upconversion Nanoparticles (II)
por: Han, Gang, et al.
Publicado: (2013)

The Pursuit of Theranostics with CEST MRI
por: Pagel, Mark Marty
Publicado: (2016)

Nanostructure-Based Theranostic Systems
por: Wang, Jun, et al.
Publicado: (2016)

Effect of Helicobacter pylori infection on antral gastrin and somatostatin cells and on serum gastrin concentrations
por: Park, Sill Moo, et al.
Publicado: (1999)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor
por: Rurarz, Beata Paulina, et al.
Publicado: (2023)

A Speculative Role for Stromal Gastrin Signaling in Development and Dissemination of Pancreatic Ductal Adenocarcinoma
por: Matters, Gail L, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t4vul9pd5slf0u7qtgq9qkgg18